tiprankstipranks
Mural Oncology Plc (MURA)
NASDAQ:MURA
US Market

Mural Oncology Plc (MURA) Income Statement

Compare
426 Followers

Mural Oncology Plc Income Statement

Last quarter (Q3 2024), Mural Oncology Plc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Mural Oncology Plc's net income was $-31.76M. See Mural Oncology Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.57M$ -1.54M$ -1.47M
Operating Expenses
$ 192.07M$ 195.15M$ 175.37M
Depreciation and Amortization
$ 2.57M$ 1.54M$ 1.47M
EBITDA
$ -192.72M$ -183.38M$ -173.89M
Operating Income
$ -194.64M$ -195.15M$ -175.37M
Other Income/Expenses
$ -649.00K$ 10.22M$ 0.00
Pretax Income
$ -195.29M$ -195.15M$ -175.37M
Net Income
$ -207.45M$ -200.03M$ -175.43M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -12.43$ -11.99$ -10.51
Diluted EPS
$ -12.43$ -11.99$ -10.51
Weighted Average Shares Outstanding
16.69M 16.69M 16.69M
Weighted Average Shares Outstanding (Diluted)
16.69M 16.69M 16.69M
Currency in USD

Mural Oncology Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis